CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-15 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-03-15 | Bancel Stephane Chief Executive Officer | Sale | −15,472 | $148.33 | $2.3M | 5,436,474 |
| 2023-03-15 | Bancel Stephane Chief Executive Officer | Sale | −22,481 | $149.03 | $3.4M | 5,413,993 |
| 2023-03-15 | Bancel Stephane Chief Executive Officer | Sale | −1,847 | $150.00 | $277K | 5,412,146 |
| 2023-03-15 | Bancel Stephane Chief Executive Officer | Sale | −200 | $150.72 | $30K | 5,411,946 |
| 2023-03-15 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 1,187,155 | ||
| 2023-03-09 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-03-09 | Bancel Stephane Chief Executive Officer | Sale | −11,461 | $137.25 | $1.6M | 5,440,485 |
| 2023-03-09 | Bancel Stephane Chief Executive Officer | Sale | −7,739 | $137.97 | $1.1M | 5,432,746 |
| 2023-03-09 | Bancel Stephane Chief Executive Officer | Sale | −3,896 | $139.24 | $542K | 5,428,850 |
| 2023-03-09 | Bancel Stephane Chief Executive Officer | Sale | −5,563 | $140.23 | $780K | 5,423,287 |
| 2023-03-09 | Bancel Stephane Chief Executive Officer | Sale | −9,232 | $141.30 | $1.3M | 5,414,055 |
| 2023-03-09 | Bancel Stephane Chief Executive Officer | Sale | −2,109 | $142.26 | $300K | 5,411,946 |
| 2023-03-09 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 1,227,155 | ||
| 2023-03-08 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-03-08 | Bancel Stephane Chief Executive Officer | Sale | −26,018 | $141.18 | $3.7M | 5,425,928 |
| 2023-03-08 | Bancel Stephane Chief Executive Officer | Sale | −13,982 | $141.76 | $2.0M | 5,411,946 |
| 2023-03-08 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 1,267,155 | ||
| 2023-03-08 | Klinger Shannon Thyme Chief Legal Officer | Sale | −561 | $141.51 | $79K | 5,820 |
| 2023-03-07 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion | +1,138 | 6,381 |
Page 53 of 66 · 1,314 trades